Sunday, June 21, 2026

HomeHealth NewsAI aids in discovery of potential glaucoma drug candidates

AI aids in discovery of potential glaucoma drug candidates

- Advertisement -

by Chinese Medical Journals Publishing House Co., Ltd.

The loss of retinal ganglion cells (RGCs) is a prevalent characteristic of glaucoma and often the reason behind disease progression. Now, a team of researchers has utilized AI to identify a RIPK3 inhibitor with neuroprotective properties. Findings can…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed